Pregabalin Capsule
Product Images NDC 71610-618

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 150 mg (71610 0618 53)

Bottle Label 150 mg (71610 0618 53)
This is a medication called Pregabalin. The package contains 60 capsules, each with a strength of 50mg. The NDC number is 71610-0618-53. There is also some information about storage temperature and identification of the lot and batch numbers.*
FDA Label Image

Bottle Label 50 mg (71610 0619 53)

Bottle Label 50 mg (71610 0619 53)
The text contains information that appears to be related to a medicine called Pregabalin with a quantity of 60 capsules, a batch number of 71810.0870.83 and an expiration date of 12/2084. It is not possible to determine any additional information or instructions without further context.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure 1 (Pregabalin Fig01)

Figure 1 (Pregabalin Fig01)
FDA Label Image

Figure 2 (Pregabalin Fig02)

Figure 2 (Pregabalin Fig02)
This seems to be a table showing the percentage improvement in pain from baseline for patients who took Pregabalin 160mg for three days. There are numbers ranging from 2 to 100 indicating the percentage of improvement for different patients. However, the rest of the text is not readable and leaves little context for further interpretation.*
FDA Label Image

Figure 3 (Pregabalin Fig03)

Figure 3 (Pregabalin Fig03)
FDA Label Image

Figure 4 (Pregabalin Fig04)

Figure 4 (Pregabalin Fig04)
FDA Label Image

Figure 5 (Pregabalin Fig05)

Figure 5 (Pregabalin Fig05)
This appears to be a table displaying the results of a study involving the administration of Fregabalin 100mg, Pregataiin 80mg, and a placebo to patients. The table shows the number of patients who improved after the treatment and the percent improvement in pain from baseline.*
FDA Label Image

Figure 6 (Pregabalin Fig06)

Figure 6 (Pregabalin Fig06)
The text seems to be a table containing two study names - E1 and E3, and a dosage list including Placebo SOmgday, 150mgday, 300mgday, and 600mgday. The table also shows that the study participants were given either Placebo, 300mg/day, or 600mg/day, and the results were statistically significant compared to the Placebo group. Therefore, the text appears to be related to a medical study testing different dosages of a drug.*
FDA Label Image

Figure 7 (Pregabalin Fig07)

Figure 7 (Pregabalin Fig07)
FDA Label Image

Figure 9 (Pregabalin Fig08)

Figure 9 (Pregabalin Fig08)
The text shows a graph that displays the percent of patients improved in relation to the daily dose of Pregabalin (300mg or 450mg) and the placebo. The horizontal axis shows the percent improvement in pain from baseline, while the vertical axis displays the percentage of patients who experienced improvement. No additional information is available.*
FDA Label Image

Figure 10 (Pregabalin Fig09)

Figure 10 (Pregabalin Fig09)
This is a table presenting the estimated percentage of subjects without LTR (likely related to a medical trial). The table indicates different percentages that range from 0% to 100% and includes two groups, Progabain and Placebo. The columns on the right side of the table display different days, from day 0 to day 180. No further information is given.*
FDA Label Image

Figure 11 (Pregabalin Fig10)

Figure 11 (Pregabalin Fig10)
FDA Label Image

Figure 12 (Pregabalin Fig11)

Figure 12 (Pregabalin Fig11)
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
The given text is a medical formula used to calculate the creatinine clearance rate (CLCT) in patients. It uses the patient's age and weight in kilograms to calculate an intermediate result (mmmmmmmmm e e) which is multiplied by 0.85 in the case of female patients. The final step in the formula involves multiplying the result by the patient's serum creatinine level measured in milligrams per deciliter (mg/dL).*
FDA Label Image

Chemical Structure (Pregabalin Str)

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.